Amphastar Pharmaceuticals (NASDAQ:AMPH) reported its Q3 earnings results on Monday, November 8, 2021 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
Amphastar Pharmaceuticals their estimated earnings by 91.67%, reporting an EPS of $0.46 versus an estimate of $0.24, which surprised analysts.
Revenue was up $28,767,000 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0, which was followed by a 1.2% increase in the share price the next day.
Here’s a look at Amphastar Pharmaceuticals’s past performance:
| Quarter | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|
| EPS Estimate | 0.21 | 0.18 | 0.14 | 0.14 |
| EPS Actual | 0.21 | 0.27 | 0.16 | 0.15 |
| Revenue Estimate | 101.78M | 97.26M | 88.94M | 91.26M |
| Revenue Actual | 101.66M | 103.02M | 95.92M | 83.43M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
